ACOG委员会意见第767号:妊娠期及产后急性发作重度高血压的紧急治疗
该委员会意见指出,妊娠期或产后急性发作重度收缩压高血压、重度舒张压高血压或两者兼有者需紧急降压治疗。应在确诊重度高血压后30-60分钟内尽快给予一线药物治疗以降低孕产妇卒中风险,静脉拉贝洛尔和肼屈嗪为长期公认的一线药物,即刻释放口服硝苯地平也可考虑作为一线治疗,尤其当无静脉通路时。若连续适当剂量的一线药物未能缓解,建议紧急会诊以讨论二线干预。
要点
- 妊娠期或产后急性发作重度高血压需紧急降压治疗。
- 确诊重度高血压后30-60分钟内尽快给予一线药物以降低孕产妇卒中风险。
- 静脉拉贝洛尔和肼屈嗪为一线药物,即刻释放口服硝苯地平也可考虑作为一线治疗。
核心结论
- 妊娠期或产后急性发作重度收缩压高血压、重度舒张压高血压或两者兼有者需要紧急降压治疗。
- 治疗应使用一线药物,并在确诊重度高血压后30-60分钟内尽快给药,以降低孕产妇卒中风险。
- 静脉拉贝洛尔和肼屈嗪长期被视为妊娠期及产后急性发作重度高血压的一线药物。
- 现有证据提示即刻释放口服硝苯地平也可考虑作为一线治疗,尤其当无静脉通路时。
- 若连续适当剂量的静脉推注拉贝洛尔、肼屈嗪或即刻释放口服硝苯地平未能缓解急性发作重度高血压,建议紧急会诊麻醉科、母胎医学专科或重症监护专科以讨论二线干预。
研究设计与样本
- 美国妇产科医师学会(ACOG)发布的委员会意见第767号。
主要发现
- 引入标准化、循证临床指南管理子痫前期和子痫患者已被证明可降低不良孕产妇结局的发生率。
- 个人和机构应建立机制,在患者出现高血压急症时立即给予药物。
- 目前关于钙通道阻滞剂用于该临床指征的信息相对较少,但现有证据提示即刻释放口服硝苯地平也可考虑作为一线治疗。
关键数值与推荐
- 确诊重度高血压后30-60分钟内尽快给予一线药物治疗。
- 静脉拉贝洛尔和肼屈嗪为一线药物。
- 即刻释放口服硝苯地平也可考虑作为一线治疗,尤其当无静脉通路时。
- 连续适当剂量的静脉推注拉贝洛尔、肼屈嗪或即刻释放口服硝苯地平未能缓解时,建议紧急会诊讨论二线干预。
临床怎么用
- 个人和机构应建立机制,在患者出现高血压急症时立即给予药物。
- 对妊娠期或产后急性发作重度高血压患者,应在确诊后30-60分钟内尽快给予一线药物治疗。
- 一线药物可选静脉拉贝洛尔或肼屈嗪;当无静脉通路时,也可考虑即刻释放口服硝苯地平。
- 若连续适当剂量的一线药物未能缓解,建议紧急会诊麻醉科、母胎医学专科或重症监护专科以讨论二线干预。
局限性
- 目前关于钙通道阻滞剂用于该临床指征的信息相对较少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute-onset, severe systolic hypertension; severe diastolic hypertension; or both can occur during the prenatal, intrapartum, or postpartum periods. Pregnant women or women in the postpartum period with acute-onset, severe systolic hypertension; severe diastolic hypertension; or both require urgent antihypertensive therapy. Introducing standardized, evidence-based clinical guidelines for the management of patients with preeclampsia and eclampsia has been demonstrated to reduce the incidence of adverse maternal outcomes. Individuals and institutions should have mechanisms in place to initiate the prompt administration of medication when a patient presents with a hypertensive emergency. Treatment with first-line agents should be expeditious and occur as soon as possible within 30-60 minutes of confirmed severe hypertension to reduce the risk of maternal stroke. Intravenous labetalol and hydralazine have long been considered first-line medications for the management of acute-onset, severe hypertension in pregnant women and women in the postpartum period. Although relatively less information currently exists for the use of calcium channel blockers for this clinical indication, the available evidence suggests that immediate release oral nifedipine also may be considered as a first-line therapy, particularly when intravenous access is not available. In the rare circumstance that intravenous bolus labetalol, hydralazine, or immediate release oral nifedipine fails to relieve acute-onset, severe hypertension and is given in successive appropriate doses, emergent consultation with an anesthesiologist, maternal-fetal medicine subspecialist, or critical care subspecialist to discuss second-line intervention is recommended.
引用
- ACOG Committee Opinion No. 767: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period. Obstet Gynecol. 2019. PMID: 30575639. doi:10.1097/AOG.0000000000003075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。